1404473-96-6Relevant articles and documents
Discovery of an l-alanine ester prodrug of the Hsp90 inhibitor, MPC-3100
Kim, Se-Ho,Tangallapally, Rajendra,Kim, In Chul,Trovato, Richard,Parker, Daniel,Patton, J. Scott,Reeves, Leslie,Bradford, Chad,Wettstein, Daniel,Baichwal, Vijay,Papac, Damon,Bajji, Ashok,Carlson, Robert,Yager, Kraig M.
, p. 5254 - 5257 (2015/11/09)
Various types of Hsp90 inhibitors have been and continue to undergo clinical investigation. One development candidate is the purine-based, synthetic Hsp90 inhibitor 1 (MPC-3100), which successfully completed a phase I clinical study. However, further clin